about
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.Are TKIs favourable for the elderly with non-small-cell lung cancer?Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectives.Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center.Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer.KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study.Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.Immunotherapy in Gastrointestinal Cancers.Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study.Bone metastases in biliary cancers: A multicenter retrospective survey
P50
Q36993182-F6DAD1B3-9EE4-45FD-81A7-416FBB443998Q37564967-495F9205-95CF-4DD0-B659-BFE7757421F7Q38448165-F41F36AC-59BA-4822-AA12-EBAF7583B43DQ38650454-BA4A6E2F-D09F-45D1-B147-A7DD73A3935DQ38782118-E789ACCA-402A-44A7-8430-83868D464F84Q41929657-2D666A65-87C2-45DE-8B45-20579FAEA3E3Q46301372-ACE76819-F429-4D8A-AF7F-BFC8C40A3959Q48097655-D3B5E3FB-3949-4ACC-82AB-273908BF2DFBQ50095277-D78FDE31-BEBD-44FE-B97D-C3C58F858C54Q52145217-9A5121D4-D498-4B5F-BC5A-9586485076B6Q53183990-EA7AD900-9399-44E2-B917-4A3E1EAA3B38Q55689035-5D8D17F0-CF64-419A-8AEA-6CD52CEFF4A9Q56387056-41482120-8300-4E20-8D16-706F2B79D807
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vincenzo Dadduzio
@ast
Vincenzo Dadduzio
@en
Vincenzo Dadduzio
@es
Vincenzo Dadduzio
@nl
Vincenzo Dadduzio
@pt
Vincenzo Dadduzio
@sl
type
label
Vincenzo Dadduzio
@ast
Vincenzo Dadduzio
@en
Vincenzo Dadduzio
@es
Vincenzo Dadduzio
@nl
Vincenzo Dadduzio
@pt
Vincenzo Dadduzio
@sl
prefLabel
Vincenzo Dadduzio
@ast
Vincenzo Dadduzio
@en
Vincenzo Dadduzio
@es
Vincenzo Dadduzio
@nl
Vincenzo Dadduzio
@pt
Vincenzo Dadduzio
@sl
P106
P21
P31
P496
0000-0002-3193-6632